Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination.
Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?
A unified cell biological perspective on axon-myelin injury.
Efficacy and safety of fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis (FREEDOMS II)
Amyotrophic lateral sclerosis and multiple sclerosis overlap: a case report.
The myelin proteolipid plasmolipin, forms oligomers and induces liquid ordered membranes in the Golgi apparatus.
Iron and multiple sclerosis.
Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.
Can multiple sclerosis as a cognitive disorder influence patients' dreams?
Phonological fluency strategy of switching differentiates relapsing-remitting and secondary progressive multiple sclerosis patients.
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
Teriflunomide (Aubagio®) for the treatment of multiple sclerosis.
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis.]
[Vitamin D in Multiple Sclerosis].
Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy.
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.
p(70S6K1) in the TORC1 Pathway is Essential for the Differentiation of Th17 Cells, but Not Th1, Th2, or Treg Cells in Mice.
Interferon Beta and vitamin d synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.
Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.
A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis.
The role of chromogranin B in an animal model of multiple sclerosis.
Deletion of Mitochondrial Anchoring Protects Dysmyelinating Shiverer: Implications for Progressive MS.
A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation.
Insights into the channel gating of P2X receptors from structures, dynamics and small molecules.
The cooling effect on proinflammatory cytokines interferon-gamma, tumor necrosis factor-alpha, and nitric oxide in patients with multiple sclerosis.
Pages
« first
‹ previous
…
421
422
423
424
425
426
427
428
429
…
next ›
last »